Cargando…

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer

Definitive radiochemotherapy is the standard treatment for many patients with locally advanced nonsmall cell lung cancer (NSCLC). Treatment outcomes have improved over the last decades. Several treatment regimens have been shown effective and safe. This review summarises the results of significant s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glatzer, Markus, Elicin, Olgun, Ramella, Sara, Nestle, Ursula, Putora, Paul Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2016
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487664/ https://www.ncbi.nlm.nih.gov/pubmed/26929423 http://dx.doi.org/10.1183/16000617.0053-2015

Ejemplares similares

Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
por: Lasalvia-Prisco, Eduardo, et al.
Publicado: (2008)

Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their Outcome
por: Elicin, Olgun, et al.
Publicado: (2020)

International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
por: Putora, Paul Martin, et al.
Publicado: (2020)

Superior loco-regional control after primary surgery compared to chemo-radiotherapy for advanced stage laryngeal cancer
por: Shelan, Mohamed, et al.
Publicado: (2023)

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement()
por: Troost, Esther G.C., et al.
Publicado: (2020)

New developments in locally advanced nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2021)

The role of radiation therapy in the management of small cell lung cancer
por: Glatzer, Markus, et al.
Publicado: (2017)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy
por: Bojaxhiu, Beat, et al.
Publicado: (2020)

Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer
por: Gridelli, Cesare, et al.
Publicado: (2011)

Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Spontaneous regression of locally advanced nonsmall cell lung cancer: A case report
por: Ooi, Kiat Huat, et al.
Publicado: (2018)

Evolving target volume concepts in locally advanced non-small cell lung cancer
por: Nestle, Ursula, et al.
Publicado: (2021)

Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy
por: Bala, Stalin, et al.
Publicado: (2016)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Modern therapies of nonsmall cell lung cancer
por: Jachowski, Andrzej, et al.
Publicado: (2023)

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
por: Li, Ling, et al.
Publicado: (2016)

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world
por: Shokoohi, Aria, et al.
Publicado: (2021)

Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
por: Bojaxhiu, Beat, et al.
Publicado: (2018)

Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
por: Simonetto, Cristoforo, et al.
Publicado: (2020)

Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?
por: Montero, Angel, et al.
Publicado: (2022)

The Possibility of Traditional Chinese Medicine as Maintenance Therapy for Advanced Nonsmall Cell Lung Cancer
por: Xu, Weiru, et al.
Publicado: (2014)

(125)I Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of Concurrent Radiochemotherapy
por: Xiang, Zhanwang, et al.
Publicado: (2015)

Stent patency in patients with distal malignant biliary obstruction receiving chemo(radio)therapy
por: Haal, Sylke, et al.
Publicado: (2017)

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy
por: Gommlich, A., et al.
Publicado: (2021)

Commentary: Immuno-chemo-radio-therapy before esophagectomy: Our next standard?
por: Ripley, R. Taylor
Publicado: (2022)

Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?
por: Jeremić, Branislav, et al.
Publicado: (2022)

Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
por: Balk, Matthias, et al.
Publicado: (2021)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?
por: Münch, Stefan, et al.
Publicado: (2017)

Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives
por: Cheng, Xinghua, et al.
Publicado: (2014)

Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma
por: Karakhanova, Svetlana, et al.
Publicado: (2014)

Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications
por: Hav, Monirath, et al.
Publicado: (2015)

Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
por: Slaney, Clare Y., et al.
Publicado: (2023)

Neoadjuvant Chemo-Immunotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Review of the Literature
por: Franzi, Sara, et al.
Publicado: (2022)

Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
por: Gong, Juejun, et al.
Publicado: (2021)

A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers
por: Ademaj, Adela, et al.
Publicado: (2022)

Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
por: Glatzer, Markus, et al.
Publicado: (2021)

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)
por: Kobayashi, Kunihiko, et al.
Publicado: (2013)

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_49k8qrq208vjk1ck0eo0g7fkm5